View full meeting coverage »

Eyetube Meeting Coverage:

2017 Retina World Congress Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

How Long-Term RVO Patients Respond to Therapy

  Channels: Retina | Posted 1/25/2017

Antonio Casella, MD, PhD, reviews his presentation on the pathophysiology and outcomes of patients with chronic retinal vein occlusion (RVO). Dr. Casella discusses how laser, anti-VEGF injections, and steroids play a role in RVO treatment, and how populations from various clinical trials have responded to therapy.

Retinal Vein Occlusion, RVO


10 / 12 Series: 2017 Retina World Congress Meeting